JW (Cayman) Therapeutics Co. Ltd (02126)
| Auditor | From | To | Release Date / Document Links | Reason for Change |
|---|---|---|---|---|
| Deloitte (Hong Kong) | 31-Oct-24 | |||
| PwC (HK) | 22-Oct-20 | 31-Oct-24 | Could not reach a consensus in respect of remuneration for the audit of the Company’s consolidated financial statements for the financial year ending December 31, 2024. |